Pain News and Research

Latest Pain News and Research

Natural dietary supplement Arthrem significantly reduces pain and stiffness in osteoarthritis patients

New Zealand company Promisia Integrative Limited, announced today significant positive results from a clinical trial on their natural dietary supplement Arthrem. The results have been published in the December 2015 issue of Clinical Rheumatology, a prestigious international peer reviewed medical journal.

31 Dec 2015

First patient enrolled in Phase 3 efficacy trial of CAM2038 for opioid dependence

Braeburn Pharmaceuticals and Camurus announce that the first patient has been randomized in the double blind Phase 3 efficacy trial of CAM2038 in opioid-dependent patients. CAM2038 medications are designed for long-acting weekly and monthly administration.

31 Dec 2015

Bond villain fails neuroanatomy, says St. Michael's Hospital neurosurgeon

James Bond's nemesis in the most recent film likely failed neuroanatomy, said real-life neurosurgeon and scientist Dr. Michael Cusimano of St. Michael's Hospital.

30 Dec 2015

Most patients with chronic pain continue to receive prescription opioids after nonfatal overdose

A study led by Boston Medical Center indicates that most patients with chronic pain who are hospitalized after a nonfatal opioid overdose continue to receive prescription opioids after the overdose and are at high risk for experiencing a repeated overdose.

30 Dec 2015

Opioid prescribing guideline has immediate, sustained impact on prescribing rates

Emergency medicine physicians at Temple University Hospital have found that an opioid prescribing guideline had an immediate and sustained impact on opioid prescribing rates for minor conditions and chronic noncancer pain in an acute care setting.

30 Dec 2015

UAB's Undiagnosed Diseases Program finds answers for mysterious health issues

Stephanie and Christopher Smith have been on a long, difficult and often frustrating journey to find answers for the mysterious health issues of their children. It started 24 years ago when their third child, Gage, was born. Gage, his younger brother Aiden and then sister Mandalynn, now 13, all developed mysterious symptoms that mystified doctors.

29 Dec 2015

Study looks at long-term effects of psychological therapies in patients with irritable bowel syndrome

For some time doctors have known that psychological therapies can reduce the symptoms of irritable bowel syndrome in the short term.

29 Dec 2015

More than 90% of patients continue to receive prescription opioids after overdose

More than 90 percent of patients with chronic pain continue to receive prescription opioids after an overdose and are at high risk for experiencing a repeated overdose, according to an article published in Annals of Internal Medicine.

29 Dec 2015

Novel 'hypnosedation' technique offers new option for patients undergoing awake surgery for gliomas

Could hypnosis help to reduce the psychological trauma associated with "awake craniotomy" for brain cancers? A new "hypnosedation" technique offers a new alternative for patients undergoing awake surgery for gliomas, suggests a study in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons, published by Wolters Kluwer.

29 Dec 2015

FDA approves non-alcoholic Docetaxel Injection

Teikoku Pharma USA, Inc. announced today that the U.S. Food and Drug Administration has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel Injection") for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.

29 Dec 2015

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Immune Pharmaceuticals Inc. a clinical-stage company developing novel therapies for the treatment of immuno-inflammatory diseases and cancer, today announced it has entered into an exclusive license with Atlante Biotech SAS, to the patents and know-how for a new format of bispecific antibodies.

29 Dec 2015

Philadelphia jury ruled in favor of plaintiff against Johnson and Johnson

Fair Rate Funding, a leader in pelvic mesh lawsuit funding, reports a jury verdict in favor of the plaintiff, Patricia Hammons and against defendant, Johnson and Johnson on Monday.

26 Dec 2015

Ultrafast near-infrared lasers deliver gene therapy to treat macular degeneration

Millions of adults over age 50 struggle each year with vision loss caused by damage to the retina or common macular degeneration.

24 Dec 2015

Selexipag holds promise for treatment of pulmonary hypertension

Living with pulmonary arterial hypertension is challenging, but the chore of treating the rare heart disease may change following promising clinical trial data to be published in the Dec. 24 issue of the New England Journal of Medicine.

24 Dec 2015

EMA CHMP considers AcelRx's ARX-04 for acute pain treatment for centralized review

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04 may be submitted in the European Union (EU) under the Agency's centralized procedure.

24 Dec 2015

Shells of plant virus trigger immune system to wipe out tumors, provide protection against metastases

The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.

23 Dec 2015

Young teens more vulnerable to opioid addiction, study reveals

A Michigan State University study shows that 14- and 15-year-olds are at a higher risk of becoming dependent on prescription drugs within a 12-month period after using them extra-medically, or beyond the prescribed amount.

23 Dec 2015

Researchers describe epigenetic mechanisms underlying the development of cerebellum

From before birth through childhood, connections form between neurons in the brain, ultimately making us who we are. So far, scientists have gained a relatively good understanding of how neural circuits become established, but they know less about the genetic control at play during this crucial developmental process.

23 Dec 2015

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need for transplantation.

22 Dec 2015

Vertice Pharma closes previously announced acquisition of VistaPharm

Vertice Pharma, a specialty pharmaceuticals company focused on improving patients' health, today announced it closed on the previously announced acquisition of VistaPharm, a specialized generics manufacturer of liquid and unit dosage pain medications for the hospital market, retail pharmacy and outpatient clinics. Terms of the transaction were not disclosed.

22 Dec 2015

Pain News and Research

Latest Pain News and Research

Natural dietary supplement Arthrem significantly reduces pain and stiffness in osteoarthritis patients

First patient enrolled in Phase 3 efficacy trial of CAM2038 for opioid dependence

Bond villain fails neuroanatomy, says St. Michael's Hospital neurosurgeon

Most patients with chronic pain continue to receive prescription opioids after nonfatal overdose

Opioid prescribing guideline has immediate, sustained impact on prescribing rates

UAB's Undiagnosed Diseases Program finds answers for mysterious health issues

Study looks at long-term effects of psychological therapies in patients with irritable bowel syndrome

More than 90% of patients continue to receive prescription opioids after overdose

Novel 'hypnosedation' technique offers new option for patients undergoing awake surgery for gliomas

FDA approves non-alcoholic Docetaxel Injection

Immune enters into exclusive license with Atlante Biotech for new format of bispecific antibodies

Philadelphia jury ruled in favor of plaintiff against Johnson and Johnson

Ultrafast near-infrared lasers deliver gene therapy to treat macular degeneration

Selexipag holds promise for treatment of pulmonary hypertension

EMA CHMP considers AcelRx's ARX-04 for acute pain treatment for centralized review

Shells of plant virus trigger immune system to wipe out tumors, provide protection against metastases

Young teens more vulnerable to opioid addiction, study reveals

Researchers describe epigenetic mechanisms underlying the development of cerebellum

FDA approves Uptravi tablets to treat adults with pulmonary arterial hypertension

Vertice Pharma closes previously announced acquisition of VistaPharm

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Pain News and Research

Latest Pain News and Research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Newsletters you may be interested in